Contribution of endothelial injury and inflammation in early phase to vein graft failure: The causal factors impact on the development of intimal hyperplasia in murine models

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Tseng, Chi Nan ^a   Karlöf, Eva ^a   Chang, Ya Ting ^a   Lengquist, Mariette ^a   Rotzius, Pierre ^a   Berggren, Per Olof ^a   Hedin, Ulf ^a   Eriksson, Einar E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GREEN FLUORESCENT PROTEIN; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GRAFT FAILURE; INFERIOR CAVA VEIN; INFLAMMATION; INTRAVITAL MICROSCOPY; LEUKOCYTE FUNCTION; LEUKOCYTE RECRUITMENT; MICROSCOPY; MOUSE; MURINE MODEL; NONHUMAN; PROMOTER REGION; SCANNING ELECTRON MICROSCOPY; TISSUE REGENERATION; TRANSGENIC MOUSE; VEIN GRAFT DISEASE; WILD TYPE; ANIMAL; DISEASE MODEL; GENETICS; GRAFT REJECTION; HYPERPLASIA; IMMUNOLOGY; INJURIES; INTIMA; LEUKOCYTE; PATHOLOGY; TRANSPLANTATION; VASCULAR ENDOTHELIUM; VEIN;

ANIMALS; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HYPERPLASIA; INFLAMMATION; LEUKOCYTES; MICE; P-SELECTIN; TUNICA INTIMA; VEINS;

EID: 84902310529     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098904     Document Type: Article

References (29)

1. Cooley BC (1998) History of vein grafting. Microsurgery 18: 234-236.
2. Ehsan A, Mann MJ, Dell'Acqua G, Tamura K, Braun-Dullaeus R, et al. (2002) Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 105: 1686-1692. (Pubitemid 34298613)
3. Grondin CM (1984) Late results of coronary artery grafting: is there a flag on the field? J Thorac Cardiovasc Surg 87: 161-166.
4. Thatte HS, Khuri SF (2001) The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg 72: S2245-2252; discussion S2267-2270.
5. Deb S, Cohen EA, Singh SK, Une D, Laupacis A, et al. (2012) Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol 60: 28-35.
6. Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, et al. (2001) Vein adaptation to arterialization in an experimental model. J Vasc Surg 33: 561-569. (Pubitemid 32215607)
7. Rocha SF, Adams RH (2009) Molecular differentiation and specialization of vascular beds. Angiogenesis 12: 139-147.
8. Eriksson EE, Karlof E, Lundmark K, Rotzius P, Hedin U, et al. (2005) Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol 25: 723-728. (Pubitemid 40463860)
9. Shyu KG (2006) Enhancement of new vessel formation by angiopoietin-2/Tie2 signaling in endothelial progenitor cells: a new hope for future therapy? Cardiovasc Res 72: 359-360.
10. Jung U, Ley K (1999) Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol 162: 6755-6762. (Pubitemid 29309402)
11. Bullard DC, Kunkel EJ, Kubo H, Hicks MJ, Lorenzo I, et al. (1996) Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in Eselectin and P-selectin double mutant mice. J Exp Med 183: 2329-2336. (Pubitemid 26158923)
12. Salzberg SP, Filsoufi F, Anyanwu A, von Harbou K, Karlof E, et al. (2006) Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes. Circulation 114: I302-307. (Pubitemid 44297167)
13. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, et al. (1998) Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 153: 1301-1310. (Pubitemid 28465854)
14. Yu P, Nguyen BT, Tao M, Campagna C, Ozaki CK (2010) Rationale and practical techniques for mouse models of early vein graft adaptations. J Vasc Surg 52: 444-452.
15. Phillips JW, Barringhaus KG, Sanders JM, Hesselbacher SE, Czarnik AC, et al. (2003) Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 107: 2244-2249. (Pubitemid 36547220)
16. Itoh Y, Toriumi H, Yamada S, Hoshino H, Suzuki N (2010) Resident Endothelial Cells Surrounding Damaged Arterial Endothelium Reendothelialize the Lesion. Arterioscler Thromb Vasc Biol: 2010;2030:1725-1732.
17. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD (1996) Susceptibility to infection and altered hematopoiesis in mice deficient in both Pand E-selectins. Cell 84: 563-574. (Pubitemid 26071737)
18. Zou Y, Hu Y, Mayr M, Dietrich H, Wick G, et al. (2000) Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res 86: 434-440. (Pubitemid 30141762)
19. Sterpetti AV, Cucina A, Lepidi S, Randone B, Stipa F, et al. (1996) Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production. J Vasc Surg 23: 568-575. (Pubitemid 26131812)
20. Zhang L, Peppel K, Brian L, Chien L, Freedman NJ (2004) Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol 24: 2277-2283. (Pubitemid 39658029)
21. Anggrahini D, Emoto N, Nakayama K, Widyantoro B, Adiarto S, et al. (2009) Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovasc Res 82: 143-151.
22. Jeremy JY, Shukla N, Angelini GD, Wan S (2011) Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonists. Pharmacol Res 63: 483-489.
23. Nakao A, Huang CS, Stolz DB, Wang Y, Franks JM, et al. (2011) Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts. Cardiovasc Res 89: 457-463.
24. Schachner T, Zou Y, Oberhuber A, Tzankov A, Mairinger T, et al. (2004) Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 77: 1580-1585. (Pubitemid 38529985)
25. Sata M, Nagai R (2004) Origin of neointimal cells in autologous vein graft. Arterioscler Thromb Vasc Biol 24: 1147-1149. (Pubitemid 38880001)
26. Wang K, Zhou X, Zhou Z, Mal N, Fan L, et al. (2005) Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury. Arterioscler Thromb Vasc Biol 25: 1584-1589. (Pubitemid 41098925)
27. Liehn EA, Schober A, Weber C (2004) Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 24: 1891-1896. (Pubitemid 39350309)
28. Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, et al. (2006) Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 70: 61-69.
29. Soehnlein O, Wantha S, Simsekyilmaz S, Doring Y, Megens RT, et al. (2011) Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med 3: 103ra198.